{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:01:00Z","timestamp":1793797260490,"version":"4.6.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110541","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:34:48Z","timestamp":1748831688000},"page":"110541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Increased c-Fos immunoreactivity in anxiety-related brain regions following paroxetine discontinuation"],"prefix":"10.1016","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-5003","authenticated-orcid":false,"given":"Helen M.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Sophie","family":"Gullino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6417-5983","authenticated-orcid":false,"given":"Raquel","family":"Pinacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Bannerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110541_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2005.03.025","article-title":"Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs","volume":"133","author":"Abrams","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110541_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/toxics10050226","article-title":"Anxiety and gene expression enhancement in mice exposed to glyphosate-based herbicide","volume":"10","author":"Ait Bali","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.neuropharm.2025.110541_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cne.901790311","article-title":"An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat","volume":"179","author":"Azmitia","year":"1978","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0166-4328(02)00268-1","article-title":"Ventral hippocampal lesions affect anxiety but not spatial learning","volume":"139","author":"Bannerman","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110541_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neubiorev.2004.03.004","article-title":"Regional dissociations within the hippocampus--memory and anxiety","volume":"28","author":"Bannerman","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110541_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0028-3908(95)00089-O","article-title":"Immediate early gene expression during morphine withdrawal","volume":"34","author":"Beckmann","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110541_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0169-328X(92)90034-9","article-title":"Activation of the zinc finger encoding gene krox-20 in adult rat brain: comparison with zif268","volume":"13","author":"Bhat","year":"1992","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110541_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.55782\/ane-2005-1554","article-title":"Expression of c-Fos in response to stressogenic stimuli in the amygdala of old vs. young rats--a preliminary study","volume":"65","author":"Boguszewski","year":"2005","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.neuropharm.2025.110541_bib9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.neuint.2010.10.001","article-title":"Biochemical and behavioral effects of long-term citalopram administration and discontinuation in rats: role of serotonin synthesis","volume":"57","author":"Bosker","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2025.110541_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cne.20354","article-title":"Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters","volume":"480","author":"Boulland","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1476-5381.1993.tb13817.x","article-title":"The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain","volume":"110","author":"Caccia","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06346","article-title":"Serotonergic neurons signal reward and punishment on multiple timescales","volume":"4","author":"Cohen","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2025.110541_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/02698811221093032","article-title":"Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice","author":"Collins","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib14","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00213-023-06442-3","article-title":"Continuous home cage monitoring of activity and sleep in mice during repeated paroxetine treatment and discontinuation","volume":"240","author":"Collins","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2025.110541_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-024-01857-8","article-title":"Rebound activation of 5-HT neurons following SSRI discontinuation","author":"Collins","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110541_bib79","doi-asserted-by":"crossref","unstructured":"Collins, H.M., 2025. C-Fos immunoreactivity in anxiety-related brain regions following paroxetine discontinuation - data [Data set]. Zenodo.","DOI":"10.1016\/j.neuropharm.2025.110541"},{"key":"10.1016\/j.neuropharm.2025.110541_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20975","article-title":"Transient inhibition and long-term facilitation of locomotion by phasic optogenetic activation of serotonin neurons","volume":"6","author":"Correia","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2025.110541_bib17","series-title":"All-Party Parliamentary Group for Prescribed Drug Dependence Report on Antidepressant Dependency and Withdrawal","author":"Davies","year":"2018"},{"key":"10.1016\/j.neuropharm.2025.110541_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addbeh.2018.08.027","article-title":"A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based?","volume":"97","author":"Davies","year":"2019","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2025.110541_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026988119100500414","article-title":"5-HT and mechanisms of defence","volume":"5","author":"Deakin","year":"1991","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib20","first-page":"449","article-title":"Neurotransmitter switching in the adult brain regulates behavior","volume":"340","author":"Dulcis","year":"2013","journal-title":"Sci. Technol. Humanit."},{"key":"10.1016\/j.neuropharm.2025.110541_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(95)01486-1","article-title":"Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety","volume":"713","author":"Duncan","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110541_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000370338","article-title":"Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review","volume":"84","author":"Fava","year":"2015","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.neuropharm.2025.110541_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14728222.12.6.717","article-title":"The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction","volume":"12","author":"Ferguson","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2025.110541_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tics.2014.11.004","article-title":"Dual serotonergic signals: a key to understanding paradoxical effects?","volume":"19","author":"Fischer","year":"2015","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib25","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1046\/j.0953-816X.2000.01334.x","article-title":"Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved","volume":"12","author":"Georges","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib26","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.celrep.2017.09.087","article-title":"Brain-wide mapping of endogenous serotonergic transmission via chemogenetic fMRI","volume":"21","author":"Giorgi","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2025.110541_bib27","first-page":"385","article-title":"Fos-like immunoreactivity in central nervous system of mice simultaneously exposed to the elevated plus-maze and nociception","volume":"41","author":"Gomes","year":"2005","journal-title":"Rev. Bras. Ciencias Farm."},{"key":"10.1016\/j.neuropharm.2025.110541_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-4328(93)90097-A","article-title":"Role of the amygdala and periaqueductal gray in anxiety and panic","volume":"58","author":"Graeff","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110541_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41467-018-08256-w","article-title":"A brain-wide functional map of the serotonergic responses toacute stress and fluoxetine","volume":"10","author":"Grandjean","year":"2019","journal-title":"Nat Comms"},{"key":"10.1016\/j.neuropharm.2025.110541_bib30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.neuropharm.2005.07.023","article-title":"Developmentally regulated expression of VGLUT3 during early post-natal life","volume":"49","author":"Gras","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110541_bib31","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1523\/JNEUROSCI.22-13-05442.2002","article-title":"A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons","volume":"22","author":"Gras","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S1461145711000484","article-title":"Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study","volume":"15","author":"Guiard","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib33","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1021\/acschemneuro.3c00758","article-title":"Evidence for a role of 5-HT-glutamate Co-releasing neurons in acute stress mechanisms","volume":"15","author":"Gullino","year":"2024","journal-title":"ACS Chem. Neurosci."},{"issue":"Suppl. 7","key":"10.1016\/j.neuropharm.2025.110541_bib34","first-page":"17","article-title":"Newer antidepressants and the discontinuation syndrome","volume":"58","author":"Haddad","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110541_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.neuroscience.2008.05.054","article-title":"Exposure to an open-field arena increases c-Fos expression in a distributed anxiety-related system projecting to the basolateral amygdaloid complex","volume":"155","author":"Hale","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110541_bib36","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1038\/s41467-024-48489-6","article-title":"Optogenetic activation of dorsal raphe serotonin neurons induces brain-wide activation","volume":"15","author":"Hamada","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110541_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0006-8993(90)90872-9","article-title":"Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain","volume":"525","author":"Hayward","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110541_bib38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S2215-0366(24)00133-0","article-title":"Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis","volume":"11","author":"Henssler","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110541_bib39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/cne.22237","article-title":"Vesicular glutamate transporter 3-expressing nonserotonergic projection neurons constitute a subregion in the rat midbrain raphe nuclei","volume":"518","author":"Hioki","year":"2010","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46464","article-title":"Molecular and anatomical organization of the dorsal raphe nucleus","volume":"8","author":"Huang","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2025.110541_bib41","article-title":"NICE updates antidepressant guidelines to reflect severity and length of withdrawal symptoms","volume":"367","author":"Iacobucci","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2025.110541_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physrev.1992.72.1.165","article-title":"Structure and function of the brain serotonin system","volume":"72","author":"Jacobs","year":"1992","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110541_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.irn.2020.11.014","article-title":"Medial prefrontal cortex encoding of stress and anxiety","volume":"158","author":"Jacobs","year":"2021","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100192","article-title":"CRF signaling between neurons in the paraventricular nucleus of the hypothalamus (PVN) coordinates stress responses","volume":"11","author":"Jiang","year":"2019","journal-title":"Neurobiology of Stress"},{"key":"10.1016\/j.neuropharm.2025.110541_bib45","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1523\/JNEUROSCI.0005-20.2020","article-title":"Decoding neurotransmitter switching: the road forward","volume":"40","author":"Li","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib46","first-page":"1252","article-title":"Generalized fear after acute stress is caused by change in neuronal cotransmitter identity","volume":"383","author":"Li","year":"2024","journal-title":"Sci. Technol. Humanit."},{"key":"10.1016\/j.neuropharm.2025.110541_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4522(03)00393-2","article-title":"Increased c-Fos expression in the centromedial nucleus of the thalamus in metabotropic glutamate 8 receptor knockout mice following the elevated plus maze test","volume":"121","author":"Linden","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110541_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature19318","article-title":"Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala","volume":"537","author":"Marcinkiewcz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110541_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1037\/0735-7044.118.1.63","article-title":"Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety","volume":"118","author":"McHugh","year":"2004","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-0327(00)00344-X","article-title":"Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety","volume":"61","author":"McNaughton","year":"2000","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2025.110541_bib51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1471-4159.1997.69020791.x","article-title":"Functional mapping of dorsal and median raphe 5\u2010hydroxytryptamine pathways in forebrain of the rat using microdialysis","volume":"69","author":"McQuade","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110541_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005346","article-title":"Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety","volume":"4","author":"Muigg","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110541_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.npp.1300334","article-title":"Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray","volume":"29","author":"Netto","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110541_bib54","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1017\/S1461145714000637","article-title":"Optogenetic activation of serotonergic neurons enhances anxiety-like behaviour in mice","volume":"17","author":"Ohmura","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107703","article-title":"Different roles of distinct serotonergic pathways in anxiety-like behavior, antidepressant-like, and anti-impulsive effects","volume":"167","author":"Ohmura","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110541_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41583-019-0151-3","article-title":"Embracing diversity in the 5-HT neuronal system","volume":"20","author":"Okaty","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib57","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55523","article-title":"A single-cell transcriptomic and anatomic atlas of mouse dorsal raphe Pet1 neurons","volume":"9","author":"Okaty","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2025.110541_bib58","doi-asserted-by":"crossref","first-page":"9767","DOI":"10.1038\/s41598-024-60759-3","article-title":"Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice","volume":"14","author":"Ozdemir","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110541_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13041-019-0492-x","article-title":"Microglial P2Y12 receptor regulates ventral hippocampal CA1 neuronal excitability and innate fear in mice","volume":"12","author":"Peng","year":"2019","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2025.110541_bib60","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1523\/JNEUROSCI.1802-19.2019","article-title":"Serotonergic plasticity in the dorsal raphe nucleus characterizes susceptibility and resilience to anhedonia","volume":"40","author":"Prakash","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib61","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cell.2018.07.043","article-title":"Anatomically defined and functionally distinct dorsal raphe serotonin sub-systems","volume":"175","author":"Ren","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110541_bib62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.biopsych.2003.10.021","article-title":"Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats","volume":"55","author":"Salom\u00e9","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110541_bib63","doi-asserted-by":"crossref","first-page":"50734","DOI":"10.1074\/jbc.M206738200","article-title":"Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons","volume":"277","author":"Sch\u00e4fer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110541_bib64","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1523\/JNEUROSCI.2238-16.2016","article-title":"Control of amygdala circuits by 5-HT neurons via 5-HT and glutamate cotransmission","volume":"37","author":"Sengupta","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/7854_2023_452","article-title":"Mechanisms of SSRI therapy and discontinuation","volume":"66","author":"Sharp","year":"2024","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2025.110541_bib66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0306-4522(90)90247-2","article-title":"Release of endogenous 5-hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphe nucleus as detected by microdialysis: sensitivity to tetrodotoxin, calcium and calcium antagonists","volume":"39","author":"Sharp","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110541_bib67","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0306-4522(00)00177-9","article-title":"Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry","volume":"98","author":"Singewald","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110541_bib68","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-3223(02)01574-3","article-title":"Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs","volume":"53","author":"Singewald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110541_bib69","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuron.2015.05.028","article-title":"Neurotransmitter switching? No surprise","volume":"86","author":"Spitzer","year":"2015","journal-title":"Neuron (Camb., Mass.)"},{"key":"10.1016\/j.neuropharm.2025.110541_bib70","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/S0024-3205(02)02138-0","article-title":"Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine","volume":"71","author":"Stenfors","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0006-8993(93)90055-R","article-title":"Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats","volume":"624","author":"Stornetta","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110541_bib72","first-page":"410","article-title":"Role of prefrontal serotonergic and dopaminergic systems in encounter-induced hyperactivity in methamphetamine-sensitized mice","volume":"20","author":"Tanaka","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110541_bib73","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.celrep.2015.10.061","article-title":"Activity of raph\u00e9 serotonergic neurons controls emotional behaviors","volume":"13","author":"Teissier","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2025.110541_bib74","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn3945","article-title":"Neuronal circuits for fear and anxiety","volume":"16","author":"Tovote","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib75","doi-asserted-by":"crossref","first-page":"Pl187","DOI":"10.1016\/0024-3205(93)90116-K","article-title":"Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat","volume":"52","author":"Trouvin","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib76","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neulet.2008.09.003","article-title":"Involvement of median raphe nucleus 5-HT1A receptors in the regulation of generalized anxiety-related defensive behaviours in rats","volume":"445","author":"Vicente","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110541_bib77","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1523\/JNEUROSCI.2787-20.2021","article-title":"Bidirectional influence of limbic GIRK channel activation on innate avoidance behavior","volume":"41","author":"Vo","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110541_bib78","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbr.2009.11.036","article-title":"Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism","volume":"208","author":"Vuong","year":"2010","journal-title":"Behav. Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:21:56Z","timestamp":1779614516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":79,"alternative-id":["S0028390825002473"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110541","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased c-Fos immunoreactivity in anxiety-related brain regions following paroxetine discontinuation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110541"}}